Showing results (181-190 of 192) with videos related to

Sort By:
Pageof 20
Blood|June 9, 2018
Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironmentFathima Zumla Cader, Ron C J Schackmann, Xihao Hu, et al.
Blood Advances|November 17, 2022
Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHLSolomon A Graf, Ryan C Lynch, Chaitra S Ujjani, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cellsStephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
American Journal of Respiratory and Critical Care Medicine|May 17, 2012
An official multi-society statement: the role of clinical research results in the practice of critical care medicineMark R Tonelli, J Randall Curtis, Kalpalatha K Guntupalli, et al.
Head & Neck|April 25, 2025
Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland CancersCristina P Rodriguez, Qian Vicky Wu, Kevin Ng, et al.
The Lancet. Haematology|July 30, 2021
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 studyRyan C Lynch, Ryan D Cassaday, Stephen D Smith, et al.
Blood Advances|November 19, 2019
CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapyVinodh Pillai, Kavitha Muralidharan, Wenzhao Meng, et al.
Blood Advances|December 10, 2019
Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasionKirsty Wienand, Bjoern Chapuy, Chip Stewart, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 9, 2015
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete RemissionAndrew J Cowan, Philip A Stevenson, Ryan D Cassaday, et al.
The New England Journal of Medicine|February 2, 2021
Dexmedetomidine or Propofol for Sedation in Mechanically Ventilated Adults with SepsisChristopher G Hughes, Patrick T Mailloux, John W Devlin, et al.
Pageof 20